| The Brighton Collaboration | |
| Type: | NPO |
| Headquarters: | Basel, Switzerland |
| Purpose: | Safest, effective vaccines based on rigorous science To enhance the science of vaccine research by providing standardized, validated, and objective methods for continuous monitoring of safety profiles and by assessing benefit-risk ratios. These methods are, in turn, recognized and recommended for use by international regulatory and public health agencies.[1] |
| Region Served: | Worldwide |
| Language: | English |
| Leader Name: | Jan Bonhoeffer, president |
| Parent Organization: | Task Force for Global Health |
| Affiliations: | Coalition for Epidemic Preparedness Innovations |
| Website: | brightoncollaboration.us |
The Brighton Collaboration (BC) is a non-profit global vaccine safety research network based in Basel, Switzerland. It is named after the city in England where the idea was first formulated.
The Brighton Collaboration was launched in 2000, although the idea of the collaboration started one year earlier, following a presentation by Bob Chen at an international scientific vaccine conference in Brighton. In his talk, he stressed the need to improve vaccine safety monitoring by developing internationally accepted standards.[2]
The Brighton Collaboration is a program of the Task Force for Global Health, a 501(c)(3) non-profit organization. It is primarily funded by the Coalition for Epidemic Preparedness Innovations (CEPI), and has received funding from a variety of scientific and public health organizations since its inception.[3]
Non-funding partners of the Collaboration include the Council for International Organizations of Medical Sciences, European Medicines Agency, Food and Drug Administration and the World Health Organization.[4]